Company / Shares Outstanding
Inhibikase Therapeutics, Inc. Shares Outstanding History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
6.2M
FY2024
5-year range
4.2M / 25.2M
FY2021-FY2024
Trend
+46.4%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from 25155198.00 to 6186280.00 over the past 2 years.
Based on SEC 10-K filings.
6186280.00 in FY2024 with a 3-year CAGR of -14.9%.
Improved from 25155198.00 to 6186280.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -14.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, shares outstanding increased 46.4% year-over-year.
Company context
Key Data Points
- Altman Z-Score 0.11 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | 6.2M | +46.4% |
| FY2023 | 4.2M | -83.2% |
| FY2022 | 25.2M | +150.3% |
| FY2021 | 10.1M | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026